Clinical Trial: A Clinical Study on the Correlation Between Exercise Intensities Corresponding to the Anaerobic Threshold (AT) Measured by the Standard Cardiopulmonary Exercise Testing Using Respiratory Gas Analysis and the Oxygen Saturation Threshold (ST) Measured by the Novel S-Slope Method in Patients with Chronic Kidney Disease (Japan)

Tokyo, Jan. 1 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000059737) titled 'A Clinical Study on the Correlation Between Exercise Intensities Corresponding to the Anaerobic Threshold (AT) Measured by the Standard Cardiopulmonary Exercise Testing Using Respiratory Gas Analysis and the Oxygen Saturation Threshold (ST) Measured by the Novel S-Slope Method in Patients with Chronic Kidney Disease' on Jan. 1.

Study Type: Observational

Primary Sponsor: Institute - Kohokai Medical Corporation, Sugamo Kidney Clinic

Condition: Condition - Chronic Kidney Disease Classification by malignancy - Others Genomic information - NO

Objective: Narrative objectives1 - To evaluate the correlation between exercise intensity at the anaerobic threshold (AT) using the "exhaled gas analysis method," a standard measurement method for cardiopulmonary exercise stress testing, and exercise intensity corresponding to the oxygen saturation threshold (ST) using the "S-Slope method," in patients with chronic kidney disease (CKD), and to examine whether ST can be used as a substitute for AT in CKD patients. Basic objectives2 - Others

Eligibility: Age-lower limit - 20 years-old = Gender - Male and Female Key inclusion criteria - 1) Patients diagnosed with chronic kidney disease (CKD) 2) Patients appropriate for exercise therapy 3) Patients aged between 20 and 80 years 4) Patients who have provided written informed consent Key exclusion criteria - 1) Patients who have intolerance to high-intensity exercise 2) Patients with exercise-induced disorders such as exercise-induced arrhythmia or exercise-induced anaphylaxis, or those with musculoskeletal impairments that limit exercise 3) Patients who wish to become pregnant during the study period, and pregnant or breastfeeding woman 4) Patients who are participating in, or are scheduled to participate in another clinical study 5) Any other patients deemed inappropriate for participation in this study Target Size - 20

Recruitment Status: Recruitment status - Preinitiation Date of protocol fixation - 2025 Year 11 Month 11 Day Anticipated trial start date - 2026 Year 01 Month 05 Day Last follow-up date - 2026 Year 06 Month 30 Day

To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000068312

Disclaimer: Curated by HT Syndication.